Culture of cytogenetically abnormal Schwann cells from benign and malignant NFI tumors

Genes Chromosomes and Cancer

Volumn 27, Issue 2, 2000, Pages 117-123

  Wallace, Margaret R ^a,b   Rasmussen, Sonja A ^a   Lim, Ingrid T ^a   Gray, Brian A ^a,b   Zori, Roberto T ^a,b   Muir, David ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; CYTOGENETICS; HUMAN; HUMAN CELL; KARYOTYPE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SCHWANN CELL; SOMATIC MUTATION; TUMOR CELL;

CELL DIVISION; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; NERVE TISSUE PROTEINS; NEUREGULIN-1; NEUROFIBROMATOSIS 1; RECOMBINANT PROTEINS; S100 PROTEINS; SCHWANN CELLS;

EID: 0033986253     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H     Document Type: Article

References (35)

1. Colman SD, Williams CA, Wallace MR. 1995. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90-92.
2. Daschner K, Assum G, Eisenbarth I, Krone W, Hoffmeyer S, Wortmann S, Heymer B, Kehrer-Sawatzki H. 1997. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Comm 234:346-350.
3. Decker H-JH, Cannizzaro LA, Mendez MJ, Leong SPL, Bixeman H, Berger C, Sandberg AA. 1990. Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease:a cytogenetic and in situ hybridization study. Hum Genet 85:337-342.
4. Glover TW, Stein CK, Legius E, Andersen LB, Brereton A, Johnson S. 1991. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer 3:62-70.
5. Gutmann DH, Collins FS. 1995. Neurofibromatosis type 1, In Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, p 677-696.
6. Jhanwar SC, Chen Q, Li FR Brennan MF, Woodruff JM. 1994. Cytogenetic analysis of soft tissue sarcomas: recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet 78:138-144.
7. Jost CA, Marin MC, Kaelin WG Jr. 1997. p73 is a human p53-related protein that can induce apoptosis. Nature 389:191-194.
8. Kamb A, Gruis NA, Weaver-Feldhaus J, Leu Q, Harshman K, Tavtigian SV, Stocken E, Day RS, Johnson BE, Skolnick MH. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
9. Legius K, Marchuk DA, Collins FS, Glover TW. 1993. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-126.
10. Legius E, Dierick H, Wu R, Hall B, Marynen P, Cassiman J, Glover T. 1994. TP53 mutations are frequent in malignant NF1 tumors. Genes Chromosomes Cancer 10:250-255.
11. Lothe RA. Saeter G, Danielsen H, Stenwig AE, Hoyheim B, O'Connell P, Borresen AL. 1993. Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1). Path Res Pract 189:465-471.
12. Lothe R, Slettan A, Saeter G, Brogger A, Borresen A, Nesland J. 1995. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropath Exp Neurol 54:65-73.
13. Martignetti J, Desnick RJ, Aliprandis E, Norton KI, Hardcastle P, Nade S, Gelb BD. 1999. Diaphyscal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22. Am J Hum Genet 64:801-807.
14. Martinsson T, Sjoberg RM, Hedborg F, Kogner P. 1997. Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma. Cancer Genet Cytogenet 95:183-189.
15. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FR Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR. 1990. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435-5439.
16. Mertens F, Rydholm A, Bauer HFC, Limon J, Nedoszytko B, Szadowska A, Willén H, Heim S, Mitelman F, Mandahl N. 1995. Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 61:793-798.
17. Muir D, Varon S, Manthorpe M. 1990. An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures. Anal Biochem 185:377-382.
18. Muir D. 1994. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 210:243-252.
19. Muir D. 1995. Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin Exp Metastasis 13:303-314.
20. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B. 1989. Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708.
21. Peltonen J, Jaakola S, Lebwohl M. 1988. Cellular differentiation and expression of matrix genes in type 1 neurofibromarosis. Lab Invest 59:760-771.
22. Petty EM, Gibson LH, Fountain JW, Bolognia JL, Yang-Feng TL, Housman DE, Bale AE. 1993. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). Am J Hum Genet 53:96-104.
23. Rao UNM, Surti U, Hoffner L, Yaw K. 1996. Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Cancer Genet Cytogenet 88:17-25.
24. Key J, Bello M, de Campos JM, Benìtez J, Sarasa JL, Boixados JR, Sánchez Cascos A. 1987. Cytogenetic clones in a recurrent neurofibroma. Cancer Genet Cytogenet 26:157-163.
25. Riccardi VM, Elder DW. 1986. Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis. Cancer Genet Cytogenet 23:199-209.
26. Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon GI. 1995. Purification and expansion of human Schwann cells in vitro. Nature Med 1:80-83.
27. Sawada S, Florell S, Purandare S, Ota M, Stephens K, Viskochil D. 1996. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 14:110-112.
28. Sawyer JR, Roloson GJ, Bell JM, Thomas JR, Teo C, Chadduck WM. 1996. Telomeric associations in the progression of chromosome aberrations in pediatric solid tumors. Cancer Genet Cytogenet 90:1-13.
29. Seabright M. 1971. A rapid banding technique for human chromosomes. Lancet 2:971-972.
30. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, Estivill X, Lazaro C. 1997. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61:512-519.
31. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F. 1994. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597-601.
32. Sheela S, Riccardi VM, Ratner N. 1990. Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol 111:645-653.
33. Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K. 1997. Homozygous inactivation of NF1 in bone marrow cells from children with neuro-fibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713-1720.
34. Skuse GR, Kosciolek BA, Rowley PT. 1989. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer 1:36-41.
35. Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CGP, Ponder BAJ. 1992. Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 4:337-342.